PRKDC and heart disorder: Consider the potential of targeting DNA-PKcs and INF2 for therapeutic interventions, the implications for patient care in cases of SIC, and how these findings might pave the way for new approaches in mitigating mitochondrial dysfunction in cardiac diseases.